PATENT CLAIM ANALYSIS

Application Number: 16403965
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "530000"]

Abstract:
Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.

Claim (Index 12):
The method according to  claim 1  wherein the at least two biodegradable sustained release implants comprise about 20% latanoprost or a salt thereof, 55% poly(D,L-lactide), 10% poly(DL-lactide-co-glycolide), and 5% polyethylene glycol.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 100.0
- Lexical Diversity: 1.72549
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14746438', '15362197', '14031657', '13011467', '11565917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8297542518264476
- 35 USC 102 Novelty (BERT): 0.553069555556354
- Combined Prediction Score: 0.8020857821994382
- Mean Citation Score: 379.532474
- Max Citation Score: 405.929
- Similarity Product: 376.9847985064984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test